Fabry disease presenting with sudden hearing loss and otosclerosis: a case report

Giovanni Felisati1, Elisabetta Salvatici, Carlotta Pipolo

  • 1Department of Otorhinolaryngology, San Paolo Hospital, University of Milan, Via A, Di Rudinì 8, 20142, Milano, Italy. carlotta.pipolo@gmail.com.

Insights

This case study highlights a patient with Fabry disease experiencing sudden hearing loss, potentially linked to otosclerosis. Standard treatments offered temporary relief, emphasizing the need for thorough hearing evaluations in Fabry disease patients.

Area of Science:

  • Genetics and rare diseases
  • Otolaryngology
  • Neurology

Background:

  • Fabry disease is an X-linked lysosomal storage disorder affecting multiple organ systems.
  • Patients with Fabry disease often experience a wide range of symptoms, including neurological, dermatological, cardiac, renal, and ocular manifestations.
  • Hearing loss is a known, though less common, symptom associated with Fabry disease.

Purpose of the Study:

  • To report a case of sudden unilateral hearing loss in a patient with Fabry disease.
  • To investigate the potential co-occurrence and connection between Fabry disease and otosclerosis.
  • To analyze the efficacy of standard sudden hearing loss treatments in a Fabry disease patient.

Main Methods:

  • Case report of a 26-year-old European Caucasian male with Fabry disease.
  • Treatment administered included glucocorticoids, pentoxifylline, hyperbaric oxygen, and fluoride for sudden hearing loss and otosclerosis.
  • Audiometric evaluation was performed to assess hearing status and evidence of otosclerosis.

Main Results:

  • The patient presented with episodic sudden unilateral hearing loss.
  • Standard treatments for sudden hearing loss provided partial and transient benefits.
  • This case is the first to describe otosclerosis-associated hearing loss in a patient with Fabry disease.

Conclusions:

  • Few data exist on treating sudden hearing loss in Fabry disease patients.
  • The pathogenesis of otological involvement in Fabry disease and its connection to otosclerosis remains unclear.
  • Thorough hearing evaluation and careful therapeutic decision-making are crucial for patients with Fabry disease.
Abstract